By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today reported a 7 percent climb in revenues to $401 million for the third quarter, beating Wall Street estimates of $396.7 million.

For the three months ended Oct. 2, the company' net income climbed 25 percent to $94.7 million, or $1.02 per share. Its non-GAAP EPS was $.98, above analyst estimates of $0.97 per share.

The figures compare to $374 million in revenues and $75.9 million in profits, or $0.79 per share, for Q3 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.